• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型基于螺环氧化吲哚的具有潜在Bcl2信号衰减作用的p53-MDM2抑制剂的设计、合成、化学及生化研究

Design, Synthesis, Chemical and Biochemical Insights Into Novel Hybrid Spirooxindole-Based p53-MDM2 Inhibitors With Potential Bcl2 Signaling Attenuation.

作者信息

Aziz Yasmine M Abdel, Lotfy Gehad, Said Mohamed M, El Ashry El Sayed H, El Tamany El Sayed H, Soliman Saied M, Abu-Serie Marwa M, Teleb Mohamed, Yousuf Sammer, Dömling Alexander, Domingo Luis R, Barakat Assem

机构信息

Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt.

Department of Chemistry, Faculty of Science, Alexandria University, Alexandria, Egypt.

出版信息

Front Chem. 2021 Dec 14;9:735236. doi: 10.3389/fchem.2021.735236. eCollection 2021.

DOI:10.3389/fchem.2021.735236
PMID:34970530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8713455/
Abstract

The tumor resistance to p53 activators posed a clinical challenge. Combination studies disclosed that concomitant administration of Bcl2 inhibitors can sensitize the tumor cells and induce apoptosis. In this study, we utilized a rapid synthetic route to synthesize two novel hybrid spirooxindole-based p53-MDM2 inhibitors endowed with Bcl2 signaling attenuation. The adducts mimic the thematic features of the chemically stable potent spiro [3-indole-3,2'-pyrrolidin]-2(1)-ones p53-MDM2 inhibitors, while installing a pyrrole ring a carbonyl spacer inspired by the natural marine or synthetic products that efficiently inhibit Bcl2 family functions. A chemical insight into the two synthesized spirooxindoles including single crystal x-ray diffraction analysis unambiguously confirmed their structures. The synthesized spirooxindoles and were preliminarily tested for cytotoxic activities against normal cells, MDA-MB 231, HepG-2, and Caco-2 MTT assay. was superior to 5-fluorouracil. Mechanistically, induced apoptosis-dependent anticancer effect (43%) higher than that of 5-fluorouracil (34.95%) in three studied cancer cell lines, activated p53 (47%), downregulated the Bcl2 gene (1.25-fold), and upregulated p21 (2-fold) in the treated cancer cells. Docking simulations declared the possible binding modes of the synthesized compounds within MDM2.

摘要

肿瘤对p53激活剂的耐药性构成了一项临床挑战。联合研究表明,同时给予Bcl2抑制剂可使肿瘤细胞敏感并诱导凋亡。在本研究中,我们采用一种快速合成路线,合成了两种新型的基于螺环氧化吲哚的p53-MDM2抑制剂,它们具有减弱Bcl2信号传导的作用。这些加合物模仿了化学稳定的强效螺[3-吲哚-3,2'-吡咯烷]-2(1)-酮p53-MDM2抑制剂的主题特征,同时引入了一个受天然海洋或合成产物启发的吡咯环和一个羰基间隔基,这些产物能有效抑制Bcl2家族功能。对这两种合成的螺环氧化吲哚进行的化学分析,包括单晶X射线衍射分析,明确证实了它们的结构。通过MTT法对合成的螺环氧化吲哚和 针对正常细胞、MDA-MB 231、HepG-2和Caco-2细胞的细胞毒性活性进行了初步测试。 优于5-氟尿嘧啶。从机制上讲, 在三种研究的癌细胞系中诱导的凋亡依赖性抗癌作用(43%)高于5-氟尿嘧啶(34.95%),激活了p53(47%),下调了Bcl2基因(1.25倍),并上调了处理过的癌细胞中的p21(2倍)。对接模拟揭示了合成化合物在MDM2内可能的结合模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/3df0d78f8b06/fchem-09-735236-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/cf18c0d01201/fchem-09-735236-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/9953e1c1a533/fchem-09-735236-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/57dfadfdb853/fchem-09-735236-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/7b9a16935798/fchem-09-735236-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/698362a55c4d/fchem-09-735236-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/8ae563529c1a/fchem-09-735236-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/952ef0406a69/fchem-09-735236-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/81814fda1d4f/fchem-09-735236-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/409312ed21c0/fchem-09-735236-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/4f1af09c3420/fchem-09-735236-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/81d711bae7fd/fchem-09-735236-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/4a0639b6a638/fchem-09-735236-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/2eb18e3f283c/fchem-09-735236-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/910d458eb766/fchem-09-735236-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/d14e916dd9ee/fchem-09-735236-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/e60d2f75ff9b/fchem-09-735236-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/eca19cbddc43/fchem-09-735236-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/67032e9fceb5/fchem-09-735236-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/3df0d78f8b06/fchem-09-735236-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/cf18c0d01201/fchem-09-735236-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/9953e1c1a533/fchem-09-735236-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/57dfadfdb853/fchem-09-735236-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/7b9a16935798/fchem-09-735236-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/698362a55c4d/fchem-09-735236-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/8ae563529c1a/fchem-09-735236-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/952ef0406a69/fchem-09-735236-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/81814fda1d4f/fchem-09-735236-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/409312ed21c0/fchem-09-735236-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/4f1af09c3420/fchem-09-735236-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/81d711bae7fd/fchem-09-735236-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/4a0639b6a638/fchem-09-735236-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/2eb18e3f283c/fchem-09-735236-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/910d458eb766/fchem-09-735236-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/d14e916dd9ee/fchem-09-735236-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/e60d2f75ff9b/fchem-09-735236-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/eca19cbddc43/fchem-09-735236-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/67032e9fceb5/fchem-09-735236-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b3/8713455/3df0d78f8b06/fchem-09-735236-g015.jpg

相似文献

1
Design, Synthesis, Chemical and Biochemical Insights Into Novel Hybrid Spirooxindole-Based p53-MDM2 Inhibitors With Potential Bcl2 Signaling Attenuation.新型基于螺环氧化吲哚的具有潜在Bcl2信号衰减作用的p53-MDM2抑制剂的设计、合成、化学及生化研究
Front Chem. 2021 Dec 14;9:735236. doi: 10.3389/fchem.2021.735236. eCollection 2021.
2
Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators.新型基于螺环吲哚的 MDM2 抑制剂的分子杂交设计与合成,具有 BCL2 信号衰减作用;向着新一代 p53 激活剂迈进了一步。
Bioorg Chem. 2021 Dec;117:105427. doi: 10.1016/j.bioorg.2021.105427. Epub 2021 Oct 13.
3
Optimized spirooxindole-pyrazole hybrids targeting the p53-MDM2 interplay induce apoptosis and synergize with doxorubicin in A549 cells.针对 p53-MDM2 相互作用的优化螺环氧化吲哚-吡唑杂合体诱导细胞凋亡,并与阿霉素在 A549 细胞中协同作用。
Sci Rep. 2023 May 8;13(1):7441. doi: 10.1038/s41598-023-31209-3.
4
Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2-p53 interaction.新型取代螺环氧化吲哚的设计与合成及其作为 MDM2-p53 相互作用抑制剂的潜力。
Bioorg Chem. 2019 May;86:598-608. doi: 10.1016/j.bioorg.2019.01.053. Epub 2019 Jan 31.
5
Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.螺环氧化吲哚衍生物5-氯-4',5'-二苯基-3'-(4-(2-(哌啶-1-基)乙氧基)苯甲酰基)螺[吲哚啉-3,2'-吡咯烷]-2-酮通过恢复p53功能触发乳腺癌细胞凋亡。
Int J Biochem Cell Biol. 2016 Jan;70:105-17. doi: 10.1016/j.biocel.2015.11.003. Epub 2015 Nov 7.
6
Discovery of Novel Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2-p53 Interaction.新型螺[3H-吲哚-3,2'-吡咯烷]-2(1H)-酮化合物作为MDM2-p53相互作用的化学稳定且口服活性抑制剂的发现
J Med Chem. 2016 Nov 23;59(22):10147-10162. doi: 10.1021/acs.jmedchem.6b00900. Epub 2016 Nov 15.
7
p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents.p53-Mdm2 相互作用抑制剂作为新型非遗传毒性抗癌药物。
Curr Cancer Drug Targets. 2018;18(8):749-772. doi: 10.2174/1568009617666170623111953.
8
Corrigendum to "Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators" [Bioorg. Chem. 117 (2021) 105427].《“基于新型螺环氧化吲哚的MDM2抑制剂的分子杂交设计与合成及其对BCL2信号传导的减弱作用;迈向新一代p53激活剂的一步”的勘误》[《生物有机化学》117 (2021) 105427]
Bioorg Chem. 2024 Feb;143:107013. doi: 10.1016/j.bioorg.2023.107013. Epub 2023 Dec 11.
9
Exploring pyrrolidinyl-spirooxindole natural products as promising platforms for the synthesis of novel spirooxindoles as EGFR/CDK2 inhibitors for halting breast cancer cells.探索吡咯烷基-螺环氧化吲哚天然产物作为合成新型螺环氧化吲哚的有前景平台,这些新型螺环氧化吲哚可作为表皮生长因子受体/细胞周期蛋白依赖性激酶2抑制剂用于阻止乳腺癌细胞生长。
Front Chem. 2024 Feb 29;12:1364378. doi: 10.3389/fchem.2024.1364378. eCollection 2024.
10
Targeted Synthesis of Complex Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-ones by Intramolecular Cyclization of Azomethine Ylides: Highly Potent MDM2-p53 Inhibitors.通过亚胺叶立德的分子内环化反应靶向合成复杂的螺[3H-吲哚-3,2'-吡咯烷]-2(1H)-酮:高效的 MDM2-p53 抑制剂。
ChemMedChem. 2019 Jan 8;14(1):88-93. doi: 10.1002/cmdc.201800617. Epub 2018 Dec 11.

引用本文的文献

1
Recent advances in the halogenated spirooxindoles as novel anticancer scaffolds: chemistry and bioactivity approach.卤代螺环氧化吲哚作为新型抗癌骨架的研究进展:化学与生物活性方法
RSC Adv. 2025 Jul 1;15(28):22336-22375. doi: 10.1039/d5ra03404c. eCollection 2025 Jun 30.
2
New spirooxindole pyrrolidine/pyrrolizidine analogs: design, synthesis, and evaluation as an anticancer agent.新型螺环氧化吲哚吡咯烷/吡咯里西啶类似物:作为抗癌剂的设计、合成与评价
RSC Adv. 2025 May 19;15(21):16623-16634. doi: 10.1039/d5ra01632k. eCollection 2025 May 15.
3
Computational identification of potential natural terpenoid inhibitors of MDM2 for breast cancer therapy: molecular docking, molecular dynamics simulation, and ADMET analysis.

本文引用的文献

1
A molecular electron density theory study of the participation of tetrazines in aza-Diels-Alder reactions.四嗪参与氮杂狄尔斯-阿尔德反应的分子电子密度理论研究
RSC Adv. 2020 Apr 21;10(26):15394-15405. doi: 10.1039/d0ra01548b. eCollection 2020 Apr 16.
2
Lactoferrin-dual drug nanoconjugate: Synergistic anti-tumor efficacy of docetaxel and the NF-κB inhibitor celastrol.乳铁蛋白-双药纳米共轭物:多西他赛与NF-κB抑制剂雷公藤红素的协同抗肿瘤疗效
Mater Sci Eng C Mater Biol Appl. 2021 Jan;118:111422. doi: 10.1016/j.msec.2020.111422. Epub 2020 Aug 23.
3
MDM2 inhibition: an important step forward in cancer therapy.
用于乳腺癌治疗的MDM2潜在天然萜类抑制剂的计算鉴定:分子对接、分子动力学模拟和ADMET分析
Front Chem. 2025 Apr 16;13:1527008. doi: 10.3389/fchem.2025.1527008. eCollection 2025.
4
The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53-MDM2 Modulation.螺环氧化吲哚类化合物在癌症治疗中的潜力:聚焦于p53-MDM2调控
Pharmaceuticals (Basel). 2025 Feb 19;18(2):274. doi: 10.3390/ph18020274.
5
Advancements in targeting tumor suppressor genes (p53 and BRCA 1/2) in breast cancer therapy.乳腺癌治疗中靶向肿瘤抑制基因(p53和BRCA 1/2)的进展。
Mol Divers. 2025 Jun;29(3):2691-2716. doi: 10.1007/s11030-024-10964-z. Epub 2024 Aug 17.
6
QiDongNing induces lung cancer cell apoptosis via triggering P53/DRP1-mediated mitochondrial fission.齐冬宁通过触发 P53/DRP1 介导的线粒体分裂诱导肺癌细胞凋亡。
J Cell Mol Med. 2024 May;28(9):e18353. doi: 10.1111/jcmm.18353.
7
Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules.螺环氧化吲哚-苯并咪唑小分子激活p53信号通路并促使乳腺癌和前列腺癌细胞消退。
Front Pharmacol. 2024 Apr 8;15:1358089. doi: 10.3389/fphar.2024.1358089. eCollection 2024.
8
Quercetin, a Flavonoid with Great Pharmacological Capacity.槲皮素,一种具有强大药理活性的黄酮类化合物。
Molecules. 2024 Feb 25;29(5):1000. doi: 10.3390/molecules29051000.
9
Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer.重新研究Passerini和Ugi支架作为多步凋亡诱导剂:对caspase 3/7和P53-MDM2信号进行双重调节以阻止乳腺癌
RSC Adv. 2023 Sep 20;13(40):27722-27737. doi: 10.1039/d3ra04029a. eCollection 2023 Sep 18.
10
Optimized spirooxindole-pyrazole hybrids targeting the p53-MDM2 interplay induce apoptosis and synergize with doxorubicin in A549 cells.针对 p53-MDM2 相互作用的优化螺环氧化吲哚-吡唑杂合体诱导细胞凋亡,并与阿霉素在 A549 细胞中协同作用。
Sci Rep. 2023 May 8;13(1):7441. doi: 10.1038/s41598-023-31209-3.
MDM2 抑制:癌症治疗的重要一步。
Leukemia. 2020 Nov;34(11):2858-2874. doi: 10.1038/s41375-020-0949-z. Epub 2020 Jul 10.
4
A Close Look to the Oxaphosphetane Formation along the Wittig Reaction: A [2+2] Cycloaddition?深入研究维蒂希反应中氧杂磷杂环丁烷的形成:[2+2]环加成反应?
J Org Chem. 2020 May 15;85(10):6675-6686. doi: 10.1021/acs.joc.0c00697. Epub 2020 Apr 28.
5
Recent Small-Molecule Inhibitors of the p53-MDM2 Protein-Protein Interaction.近期的 p53-MDM2 蛋白-蛋白相互作用小分子抑制剂。
Molecules. 2020 Mar 7;25(5):1211. doi: 10.3390/molecules25051211.
6
Dual VEGFR-2/PIM-1 kinase inhibition towards surmounting the resistance to antiangiogenic agents via hybrid pyridine and thienopyridine-based scaffolds: Design, synthesis and biological evaluation.基于杂环吡啶和噻吩吡啶骨架的双重 VEGFR-2/PIM-1 激酶抑制作用克服抗血管生成药物的耐药性:设计、合成与生物评价。
Bioorg Chem. 2019 Nov;92:103189. doi: 10.1016/j.bioorg.2019.103189. Epub 2019 Aug 8.
7
Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2-p53 interaction.新型取代螺环氧化吲哚的设计与合成及其作为 MDM2-p53 相互作用抑制剂的潜力。
Bioorg Chem. 2019 May;86:598-608. doi: 10.1016/j.bioorg.2019.01.053. Epub 2019 Jan 31.
8
Synthesis of new thiazolo-pyrrolidine-(spirooxindole) tethered to 3-acylindole as anticancer agents.合成新型噻唑并吡咯烷-(螺吲哚)连接 3-乙酰基吲哚作为抗癌剂。
Bioorg Chem. 2019 Feb;82:423-430. doi: 10.1016/j.bioorg.2018.10.036. Epub 2018 Oct 23.
9
Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents.小分子Mcl-1抑制剂:新兴的抗肿瘤药物。
Eur J Med Chem. 2018 Feb 25;146:471-482. doi: 10.1016/j.ejmech.2018.01.076. Epub 2018 Jan 31.
10
Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf mouse model.在Arf小鼠模型中通过体内piggyBac转座子诱变筛选鉴定出的对TP53-MDM2抑制的抗性机制。
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3151-3156. doi: 10.1073/pnas.1620262114. Epub 2017 Mar 6.